Global Crohn’s Disease Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The Global Crohn’s Disease Therapeutics Market Size was estimated at USD 3470.21 million in 2023 and is projected to reach USD 3772.10 million by 2029, exhibiting a CAGR of 1.40% during the forecast period.
This report provides a deep insight into the global Crohn’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Crohn’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Crohn’s Disease Therapeutics market in any manner.
Global Crohn’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Market Segmentation (by Type)
Non-Surgical
Surgical
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Centers
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Crohn’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
The Global Crohn’s Disease Therapeutics Market Size was estimated at USD 3470.21 million in 2023 and is projected to reach USD 3772.10 million by 2029, exhibiting a CAGR of 1.40% during the forecast period.
This report provides a deep insight into the global Crohn’s Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Crohn’s Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Crohn’s Disease Therapeutics market in any manner.
Global Crohn’s Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Market Segmentation (by Type)
Non-Surgical
Surgical
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Centers
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Crohn’s Disease Therapeutics Market
- Overview of the regional outlook of the Crohn’s Disease Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Crohn’s Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Crohn’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Crohn’s Disease Therapeutics Segment by Type
1.2.2 Crohn’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CROHN’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Crohn’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Crohn’s Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CROHN’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Crohn’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Crohn’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Crohn’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Crohn’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Crohn’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Crohn’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CROHN’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Crohn’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CROHN’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Crohn’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Crohn’s Disease Therapeutics Price by Type (2019-2024)
7 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Crohn’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Crohn’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Crohn’s Disease Therapeutics Sales by Region
8.1.1 Global Crohn’s Disease Therapeutics Sales by Region
8.1.2 Global Crohn’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Crohn’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Crohn’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Crohn’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Crohn’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Crohn’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson Services Inc.
9.1.1 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Basic Information
9.1.2 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Overview
9.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Market Performance
9.1.4 Johnson and Johnson Services Inc. Business Overview
9.1.5 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics SWOT Analysis
9.1.6 Johnson and Johnson Services Inc. Recent Developments
9.2 Pfizer Inc.
9.2.1 Pfizer Inc. Crohn’s Disease Therapeutics Basic Information
9.2.2 Pfizer Inc. Crohn’s Disease Therapeutics Product Overview
9.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Product Market Performance
9.2.4 Pfizer Inc. Business Overview
9.2.5 Pfizer Inc. Crohn’s Disease Therapeutics SWOT Analysis
9.2.6 Pfizer Inc. Recent Developments
9.3 Allergan
9.3.1 Allergan Crohn’s Disease Therapeutics Basic Information
9.3.2 Allergan Crohn’s Disease Therapeutics Product Overview
9.3.3 Allergan Crohn’s Disease Therapeutics Product Market Performance
9.3.4 Allergan Crohn’s Disease Therapeutics SWOT Analysis
9.3.5 Allergan Business Overview
9.3.6 Allergan Recent Developments
9.4 AbbVie Inc.
9.4.1 AbbVie Inc. Crohn’s Disease Therapeutics Basic Information
9.4.2 AbbVie Inc. Crohn’s Disease Therapeutics Product Overview
9.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Product Market Performance
9.4.4 AbbVie Inc. Business Overview
9.4.5 AbbVie Inc. Recent Developments
9.5 Takeda Pharmaceutical Company Limited
9.5.1 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Basic Information
9.5.2 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Overview
9.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Market Performance
9.5.4 Takeda Pharmaceutical Company Limited Business Overview
9.5.5 Takeda Pharmaceutical Company Limited Recent Developments
9.6 Celgene Corporation
9.6.1 Celgene Corporation Crohn’s Disease Therapeutics Basic Information
9.6.2 Celgene Corporation Crohn’s Disease Therapeutics Product Overview
9.6.3 Celgene Corporation Crohn’s Disease Therapeutics Product Market Performance
9.6.4 Celgene Corporation Business Overview
9.6.5 Celgene Corporation Recent Developments
9.7 Perrigo Company PLC
9.7.1 Perrigo Company PLC Crohn’s Disease Therapeutics Basic Information
9.7.2 Perrigo Company PLC Crohn’s Disease Therapeutics Product Overview
9.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Product Market Performance
9.7.4 Perrigo Company PLC Business Overview
9.7.5 Perrigo Company PLC Recent Developments
9.8 Ferring B.V.
9.8.1 Ferring B.V. Crohn’s Disease Therapeutics Basic Information
9.8.2 Ferring B.V. Crohn’s Disease Therapeutics Product Overview
9.8.3 Ferring B.V. Crohn’s Disease Therapeutics Product Market Performance
9.8.4 Ferring B.V. Business Overview
9.8.5 Ferring B.V. Recent Developments
9.9 Salix Pharmaceuticals
9.9.1 Salix Pharmaceuticals Crohn’s Disease Therapeutics Basic Information
9.9.2 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Overview
9.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Market Performance
9.9.4 Salix Pharmaceuticals Business Overview
9.9.5 Salix Pharmaceuticals Recent Developments
9.10 Gilead Sciences Inc.
9.10.1 Gilead Sciences Inc. Crohn’s Disease Therapeutics Basic Information
9.10.2 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Overview
9.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Market Performance
9.10.4 Gilead Sciences Inc. Business Overview
9.10.5 Gilead Sciences Inc. Recent Developments
9.11 Genentech Inc.
9.11.1 Genentech Inc. Crohn’s Disease Therapeutics Basic Information
9.11.2 Genentech Inc. Crohn’s Disease Therapeutics Product Overview
9.11.3 Genentech Inc. Crohn’s Disease Therapeutics Product Market Performance
9.11.4 Genentech Inc. Business Overview
9.11.5 Genentech Inc. Recent Developments
9.12 UCB India Private Limited.
9.12.1 UCB India Private Limited. Crohn’s Disease Therapeutics Basic Information
9.12.2 UCB India Private Limited. Crohn’s Disease Therapeutics Product Overview
9.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Product Market Performance
9.12.4 UCB India Private Limited. Business Overview
9.12.5 UCB India Private Limited. Recent Developments
10 CROHN’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Crohn’s Disease Therapeutics Market Size Forecast
10.2 Global Crohn’s Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Crohn’s Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Crohn’s Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Crohn’s Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Crohn’s Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Crohn’s Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Crohn’s Disease Therapeutics by Type (2025-2030)
11.1.2 Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Crohn’s Disease Therapeutics by Type (2025-2030)
11.2 Global Crohn’s Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Crohn’s Disease Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Crohn’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Crohn’s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Crohn’s Disease Therapeutics Segment by Type
1.2.2 Crohn’s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CROHN’S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Crohn’s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Crohn’s Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CROHN’S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Crohn’s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Crohn’s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Crohn’s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Crohn’s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Crohn’s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Crohn’s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CROHN’S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Crohn’s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CROHN’S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Crohn’s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Crohn’s Disease Therapeutics Price by Type (2019-2024)
7 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Crohn’s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Crohn’s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 CROHN’S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Crohn’s Disease Therapeutics Sales by Region
8.1.1 Global Crohn’s Disease Therapeutics Sales by Region
8.1.2 Global Crohn’s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Crohn’s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Crohn’s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Crohn’s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Crohn’s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Crohn’s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Johnson and Johnson Services Inc.
9.1.1 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Basic Information
9.1.2 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Overview
9.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Market Performance
9.1.4 Johnson and Johnson Services Inc. Business Overview
9.1.5 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics SWOT Analysis
9.1.6 Johnson and Johnson Services Inc. Recent Developments
9.2 Pfizer Inc.
9.2.1 Pfizer Inc. Crohn’s Disease Therapeutics Basic Information
9.2.2 Pfizer Inc. Crohn’s Disease Therapeutics Product Overview
9.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Product Market Performance
9.2.4 Pfizer Inc. Business Overview
9.2.5 Pfizer Inc. Crohn’s Disease Therapeutics SWOT Analysis
9.2.6 Pfizer Inc. Recent Developments
9.3 Allergan
9.3.1 Allergan Crohn’s Disease Therapeutics Basic Information
9.3.2 Allergan Crohn’s Disease Therapeutics Product Overview
9.3.3 Allergan Crohn’s Disease Therapeutics Product Market Performance
9.3.4 Allergan Crohn’s Disease Therapeutics SWOT Analysis
9.3.5 Allergan Business Overview
9.3.6 Allergan Recent Developments
9.4 AbbVie Inc.
9.4.1 AbbVie Inc. Crohn’s Disease Therapeutics Basic Information
9.4.2 AbbVie Inc. Crohn’s Disease Therapeutics Product Overview
9.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Product Market Performance
9.4.4 AbbVie Inc. Business Overview
9.4.5 AbbVie Inc. Recent Developments
9.5 Takeda Pharmaceutical Company Limited
9.5.1 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Basic Information
9.5.2 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Overview
9.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Market Performance
9.5.4 Takeda Pharmaceutical Company Limited Business Overview
9.5.5 Takeda Pharmaceutical Company Limited Recent Developments
9.6 Celgene Corporation
9.6.1 Celgene Corporation Crohn’s Disease Therapeutics Basic Information
9.6.2 Celgene Corporation Crohn’s Disease Therapeutics Product Overview
9.6.3 Celgene Corporation Crohn’s Disease Therapeutics Product Market Performance
9.6.4 Celgene Corporation Business Overview
9.6.5 Celgene Corporation Recent Developments
9.7 Perrigo Company PLC
9.7.1 Perrigo Company PLC Crohn’s Disease Therapeutics Basic Information
9.7.2 Perrigo Company PLC Crohn’s Disease Therapeutics Product Overview
9.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Product Market Performance
9.7.4 Perrigo Company PLC Business Overview
9.7.5 Perrigo Company PLC Recent Developments
9.8 Ferring B.V.
9.8.1 Ferring B.V. Crohn’s Disease Therapeutics Basic Information
9.8.2 Ferring B.V. Crohn’s Disease Therapeutics Product Overview
9.8.3 Ferring B.V. Crohn’s Disease Therapeutics Product Market Performance
9.8.4 Ferring B.V. Business Overview
9.8.5 Ferring B.V. Recent Developments
9.9 Salix Pharmaceuticals
9.9.1 Salix Pharmaceuticals Crohn’s Disease Therapeutics Basic Information
9.9.2 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Overview
9.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Market Performance
9.9.4 Salix Pharmaceuticals Business Overview
9.9.5 Salix Pharmaceuticals Recent Developments
9.10 Gilead Sciences Inc.
9.10.1 Gilead Sciences Inc. Crohn’s Disease Therapeutics Basic Information
9.10.2 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Overview
9.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Market Performance
9.10.4 Gilead Sciences Inc. Business Overview
9.10.5 Gilead Sciences Inc. Recent Developments
9.11 Genentech Inc.
9.11.1 Genentech Inc. Crohn’s Disease Therapeutics Basic Information
9.11.2 Genentech Inc. Crohn’s Disease Therapeutics Product Overview
9.11.3 Genentech Inc. Crohn’s Disease Therapeutics Product Market Performance
9.11.4 Genentech Inc. Business Overview
9.11.5 Genentech Inc. Recent Developments
9.12 UCB India Private Limited.
9.12.1 UCB India Private Limited. Crohn’s Disease Therapeutics Basic Information
9.12.2 UCB India Private Limited. Crohn’s Disease Therapeutics Product Overview
9.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Product Market Performance
9.12.4 UCB India Private Limited. Business Overview
9.12.5 UCB India Private Limited. Recent Developments
10 CROHN’S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Crohn’s Disease Therapeutics Market Size Forecast
10.2 Global Crohn’s Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Crohn’s Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Crohn’s Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Crohn’s Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Crohn’s Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Crohn’s Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Crohn’s Disease Therapeutics by Type (2025-2030)
11.1.2 Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Crohn’s Disease Therapeutics by Type (2025-2030)
11.2 Global Crohn’s Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Crohn’s Disease Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Crohn’s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Crohn’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Crohn’s Disease Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Crohn’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Crohn’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Crohn’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2022)
Table 10. Global Market Crohn’s Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Crohn’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Crohn’s Disease Therapeutics Product Type
Table 13. Global Crohn’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Crohn’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Crohn’s Disease Therapeutics Market Challenges
Table 22. Global Crohn’s Disease Therapeutics Sales by Type (K Units)
Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Crohn’s Disease Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Crohn’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Crohn’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Crohn’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Crohn’s Disease Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Crohn’s Disease Therapeutics Sales (K Units) by Application
Table 30. Global Crohn’s Disease Therapeutics Market Size by Application
Table 31. Global Crohn’s Disease Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Crohn’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Crohn’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Crohn’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Crohn’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Basic Information
Table 44. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Overview
Table 45. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Services Inc. Business Overview
Table 47. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics SWOT Analysis
Table 48. Johnson and Johnson Services Inc. Recent Developments
Table 49. Pfizer Inc. Crohn’s Disease Therapeutics Basic Information
Table 50. Pfizer Inc. Crohn’s Disease Therapeutics Product Overview
Table 51. Pfizer Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Crohn’s Disease Therapeutics SWOT Analysis
Table 54. Pfizer Inc. Recent Developments
Table 55. Allergan Crohn’s Disease Therapeutics Basic Information
Table 56. Allergan Crohn’s Disease Therapeutics Product Overview
Table 57. Allergan Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Allergan Crohn’s Disease Therapeutics SWOT Analysis
Table 59. Allergan Business Overview
Table 60. Allergan Recent Developments
Table 61. AbbVie Inc. Crohn’s Disease Therapeutics Basic Information
Table 62. AbbVie Inc. Crohn’s Disease Therapeutics Product Overview
Table 63. AbbVie Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AbbVie Inc. Business Overview
Table 65. AbbVie Inc. Recent Developments
Table 66. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Basic Information
Table 67. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Overview
Table 68. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Takeda Pharmaceutical Company Limited Business Overview
Table 70. Takeda Pharmaceutical Company Limited Recent Developments
Table 71. Celgene Corporation Crohn’s Disease Therapeutics Basic Information
Table 72. Celgene Corporation Crohn’s Disease Therapeutics Product Overview
Table 73. Celgene Corporation Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Recent Developments
Table 76. Perrigo Company PLC Crohn’s Disease Therapeutics Basic Information
Table 77. Perrigo Company PLC Crohn’s Disease Therapeutics Product Overview
Table 78. Perrigo Company PLC Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Perrigo Company PLC Business Overview
Table 80. Perrigo Company PLC Recent Developments
Table 81. Ferring B.V. Crohn’s Disease Therapeutics Basic Information
Table 82. Ferring B.V. Crohn’s Disease Therapeutics Product Overview
Table 83. Ferring B.V. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ferring B.V. Business Overview
Table 85. Ferring B.V. Recent Developments
Table 86. Salix Pharmaceuticals Crohn’s Disease Therapeutics Basic Information
Table 87. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Overview
Table 88. Salix Pharmaceuticals Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Salix Pharmaceuticals Business Overview
Table 90. Salix Pharmaceuticals Recent Developments
Table 91. Gilead Sciences Inc. Crohn’s Disease Therapeutics Basic Information
Table 92. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Overview
Table 93. Gilead Sciences Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Gilead Sciences Inc. Business Overview
Table 95. Gilead Sciences Inc. Recent Developments
Table 96. Genentech Inc. Crohn’s Disease Therapeutics Basic Information
Table 97. Genentech Inc. Crohn’s Disease Therapeutics Product Overview
Table 98. Genentech Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genentech Inc. Business Overview
Table 100. Genentech Inc. Recent Developments
Table 101. UCB India Private Limited. Crohn’s Disease Therapeutics Basic Information
Table 102. UCB India Private Limited. Crohn’s Disease Therapeutics Product Overview
Table 103. UCB India Private Limited. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. UCB India Private Limited. Business Overview
Table 105. UCB India Private Limited. Recent Developments
Table 106. Global Crohn’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Crohn’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Crohn’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Crohn’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Crohn’s Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Crohn’s Disease Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Crohn’s Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Crohn’s Disease Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Crohn’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Crohn’s Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Crohn’s Disease Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Crohn’s Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Crohn’s Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Crohn’s Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2022)
Table 10. Global Market Crohn’s Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Crohn’s Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Crohn’s Disease Therapeutics Product Type
Table 13. Global Crohn’s Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Crohn’s Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Crohn’s Disease Therapeutics Market Challenges
Table 22. Global Crohn’s Disease Therapeutics Sales by Type (K Units)
Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Crohn’s Disease Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Crohn’s Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Crohn’s Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Crohn’s Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Crohn’s Disease Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Crohn’s Disease Therapeutics Sales (K Units) by Application
Table 30. Global Crohn’s Disease Therapeutics Market Size by Application
Table 31. Global Crohn’s Disease Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Crohn’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Crohn’s Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Crohn’s Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Crohn’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Crohn’s Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Crohn’s Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Basic Information
Table 44. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Overview
Table 45. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Johnson and Johnson Services Inc. Business Overview
Table 47. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics SWOT Analysis
Table 48. Johnson and Johnson Services Inc. Recent Developments
Table 49. Pfizer Inc. Crohn’s Disease Therapeutics Basic Information
Table 50. Pfizer Inc. Crohn’s Disease Therapeutics Product Overview
Table 51. Pfizer Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Crohn’s Disease Therapeutics SWOT Analysis
Table 54. Pfizer Inc. Recent Developments
Table 55. Allergan Crohn’s Disease Therapeutics Basic Information
Table 56. Allergan Crohn’s Disease Therapeutics Product Overview
Table 57. Allergan Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Allergan Crohn’s Disease Therapeutics SWOT Analysis
Table 59. Allergan Business Overview
Table 60. Allergan Recent Developments
Table 61. AbbVie Inc. Crohn’s Disease Therapeutics Basic Information
Table 62. AbbVie Inc. Crohn’s Disease Therapeutics Product Overview
Table 63. AbbVie Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AbbVie Inc. Business Overview
Table 65. AbbVie Inc. Recent Developments
Table 66. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Basic Information
Table 67. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Overview
Table 68. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Takeda Pharmaceutical Company Limited Business Overview
Table 70. Takeda Pharmaceutical Company Limited Recent Developments
Table 71. Celgene Corporation Crohn’s Disease Therapeutics Basic Information
Table 72. Celgene Corporation Crohn’s Disease Therapeutics Product Overview
Table 73. Celgene Corporation Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Recent Developments
Table 76. Perrigo Company PLC Crohn’s Disease Therapeutics Basic Information
Table 77. Perrigo Company PLC Crohn’s Disease Therapeutics Product Overview
Table 78. Perrigo Company PLC Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Perrigo Company PLC Business Overview
Table 80. Perrigo Company PLC Recent Developments
Table 81. Ferring B.V. Crohn’s Disease Therapeutics Basic Information
Table 82. Ferring B.V. Crohn’s Disease Therapeutics Product Overview
Table 83. Ferring B.V. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Ferring B.V. Business Overview
Table 85. Ferring B.V. Recent Developments
Table 86. Salix Pharmaceuticals Crohn’s Disease Therapeutics Basic Information
Table 87. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Overview
Table 88. Salix Pharmaceuticals Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Salix Pharmaceuticals Business Overview
Table 90. Salix Pharmaceuticals Recent Developments
Table 91. Gilead Sciences Inc. Crohn’s Disease Therapeutics Basic Information
Table 92. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Overview
Table 93. Gilead Sciences Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Gilead Sciences Inc. Business Overview
Table 95. Gilead Sciences Inc. Recent Developments
Table 96. Genentech Inc. Crohn’s Disease Therapeutics Basic Information
Table 97. Genentech Inc. Crohn’s Disease Therapeutics Product Overview
Table 98. Genentech Inc. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Genentech Inc. Business Overview
Table 100. Genentech Inc. Recent Developments
Table 101. UCB India Private Limited. Crohn’s Disease Therapeutics Basic Information
Table 102. UCB India Private Limited. Crohn’s Disease Therapeutics Product Overview
Table 103. UCB India Private Limited. Crohn’s Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. UCB India Private Limited. Business Overview
Table 105. UCB India Private Limited. Recent Developments
Table 106. Global Crohn’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Crohn’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Crohn’s Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Crohn’s Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Crohn’s Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Crohn’s Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Crohn’s Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Crohn’s Disease Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Crohn’s Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Crohn’s Disease Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Crohn’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Crohn’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Crohn’s Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Crohn’s Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Crohn’s Disease Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Crohn’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Crohn’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Crohn’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Crohn’s Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Crohn’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Crohn’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Crohn’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Crohn’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Crohn’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Crohn’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Crohn’s Disease Therapeutics Market Share by Application
Figure 24. Global Crohn’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Crohn’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Crohn’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Crohn’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Crohn’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Crohn’s Disease Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Crohn’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Crohn’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Crohn’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Crohn’s Disease Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Crohn’s Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Crohn’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Crohn’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Crohn’s Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Crohn’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Crohn’s Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Crohn’s Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Crohn’s Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Crohn’s Disease Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Crohn’s Disease Therapeutics Market Size by Country (M USD)
Figure 11. Crohn’s Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Crohn’s Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Crohn’s Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Crohn’s Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Crohn’s Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Crohn’s Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Crohn’s Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Crohn’s Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Crohn’s Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Crohn’s Disease Therapeutics Market Share by Application
Figure 24. Global Crohn’s Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Crohn’s Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Crohn’s Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Crohn’s Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Crohn’s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Crohn’s Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Crohn’s Disease Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Crohn’s Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Crohn’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Crohn’s Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Crohn’s Disease Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Crohn’s Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Crohn’s Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Crohn’s Disease Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Crohn’s Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Crohn’s Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Crohn’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Crohn’s Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Crohn’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
